(Q33760173)

29 July 2017

Final trial report of sentinel-node biopsy versus nodal observation in melanoma (English)

1 reference

29 July 2017

0 references

1

Donald L Morton

1 reference

29 July 2017

17

Robert Elashoff

1 reference

29 July 2017

4

Nicola Mozzillo

1 reference

29 July 2017

John F Thompson

2

1 reference

29 July 2017

Alistair J Cochran

3

1 reference

29 July 2017

Omgo E Nieweg

5

1 reference

29 July 2017

Daniel F Roses

6

1 reference

29 July 2017

Harold J Hoekstra

7

1 reference

29 July 2017

Constantine P Karakousis

8

1 reference

29 July 2017

Christopher A Puleo

9

1 reference

29 July 2017

Brendon J Coventry

10

1 reference

29 July 2017

Mohammed Kashani-Sabet

11

1 reference

29 July 2017

B Mark Smithers

12

1 reference

29 July 2017

Eberhard Paul

13

1 reference

29 July 2017

William G Kraybill

14

1 reference

29 July 2017

J Gregory McKinnon

15

1 reference

29 July 2017

He-Jing Wang

16

1 reference

29 July 2017

Mark B Faries

18

1 reference

29 July 2017

MSLT Group

19

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 February 2014

1 reference

The New England Journal of Medicine

29 July 2017

1 reference

29 July 2017

370

1 reference

29 July 2017

599-609

1 reference

29 July 2017

7

1 reference

Late recurrence in melanoma: clinical implications of lost dormancy

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

Latent subgroup analysis of a randomized clinical trial through a semiparametric accelerated failure time mixture model

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

Final version of 2009 AJCC melanoma staging and classification

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

The rationale for sentinel-node biopsy in primary melanoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

Sentinel-node biopsy or nodal observation in melanoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

Excision margins in high-risk malignant melanoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

Inefficacy of immediate node dissection in stage 1 melanoma of the limbs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

Tumor thickness as a guide to surgical management of clinical stage I melanoma patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4058881

Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial

30 October 2018

1 reference

12 December 2020

The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma

1 reference

12 December 2020

A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma.Preliminary results

1 reference

12 December 2020

Detection of S-100 protein as an aid to the identification of melanocytic tumors

1 reference

12 December 2020

Technical details of intraoperative lymphatic mapping for early stage melanoma

1 reference

12 December 2020

Authors' response to a letter to the editor re: Sentinel node biopsy for early-stage melanoma

1 reference

12 December 2020

Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMOA1310460

1 reference

29 July 2017

1 reference

29 July 2017

1 reference